Hydroflumethiazide
Back to searchMolecule Structure
Scientific Name
Hydroflumethiazide
Description of the Drug
Hydroflumethiazide is a thiazide diuretic used to treat hypertension as well as edema due to congestive heart failure and liver cirrhosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00774
http://www.drugbank.ca/drugs/DB00774
Brand Name(s)
Diucardin, Hydrenox, Hydroflumethiazide, Saluron
Company Owner(s)
Usl Pharma Inc, Wyeth Ayerst Laboratories, Shire Development Llc, Watson Laboratories Inc, Par Pharmaceutical Inc, Shire Development Inc, Ivax Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Thiazide-sensitive sodium-chloride cotransporter | SINGLE PROTEIN | INHIBITOR | CHEMBL1876 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL27028 |
PharmGKB | PA164752557 |
Human Metabolome Database | HMDB0014912 |
DrugBank | DB00774 |
PubChem: Thomson Pharma | 15025410 |
PubChem | 3647 |
Mcule | MCULE-8204847370 |
LINCS | LSM-5497 |
Nikkaji | J2.529A |
PDBe | HFZ |
BindingDB | 25897 |
EPA CompTox Dashboard | DTXSID3023132 |
DrugCentral | 1392 |
ChemicalBook | CB5416596 |
Guide to Pharmacology | 7197 |
rxnorm | HYDROFLUMETHIAZIDE |
KEGG Ligand | C07763 |
ChEBI | 5784 |
ZINC | ZINC000000897225 |